AMRX
Price
$7.75
Change
-$0.21 (-2.64%)
Updated
Jun 13 closing price
Capitalization
1.87B
54 days until earnings call
RMTI
Price
$0.94
Change
-$0.03 (-3.09%)
Updated
Jun 13 closing price
Capitalization
49.87M
64 days until earnings call
Interact to see
Advertisement

AMRX vs RMTI

Header iconAMRX vs RMTI Comparison
Open Charts AMRX vs RMTIBanner chart's image
Amneal Pharmaceuticals
Price$7.75
Change-$0.21 (-2.64%)
Volume$1.4M
Capitalization1.87B
Rockwell Medical
Price$0.94
Change-$0.03 (-3.09%)
Volume$229.82K
Capitalization49.87M
AMRX vs RMTI Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. RMTI commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and RMTI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (AMRX: $7.75 vs. RMTI: $0.94)
Brand notoriety: AMRX and RMTI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 75% vs. RMTI: 111%
Market capitalization -- AMRX: $1.87B vs. RMTI: $49.87M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. RMTI’s [@Pharmaceuticals: Other] market capitalization is $49.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than RMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while RMTI’s TA Score has 3 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • RMTI’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than RMTI.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.71% price change this week, while RMTI (@Pharmaceuticals: Other) price change was -7.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

RMTI is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than RMTI($49.9M). AMRX YTD gains are higher at: -2.146 vs. RMTI (-53.922). AMRX has higher annual earnings (EBITDA): 400M vs. RMTI (-4.69M). AMRX has more cash in the bank: 91.5M vs. RMTI (10.9M). RMTI has less debt than AMRX: RMTI (13.4M) vs AMRX (2.75B). AMRX has higher revenues than RMTI: AMRX (2.39B) vs RMTI (83.6M).
AMRXRMTIAMRX / RMTI
Capitalization1.87B49.9M3,747%
EBITDA400M-4.69M-8,522%
Gain YTD-2.146-53.9224%
P/E Ratio90.00N/A-
Revenue2.39B83.6M2,864%
Total Cash91.5M10.9M839%
Total Debt2.75B13.4M20,530%
FUNDAMENTALS RATINGS
AMRX vs RMTI: Fundamental Ratings
AMRX
RMTI
OUTLOOK RATING
1..100
6717
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
5392
P/E GROWTH RATING
1..100
24100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (42) in the Medical Specialties industry is somewhat better than the same rating for AMRX (92) in the Pharmaceuticals Major industry. This means that RMTI’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (59) in the Pharmaceuticals Major industry is somewhat better than the same rating for RMTI (100) in the Medical Specialties industry. This means that AMRX’s stock grew somewhat faster than RMTI’s over the last 12 months.

RMTI's SMR Rating (91) in the Medical Specialties industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that RMTI’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Price Growth Rating (53) in the Pharmaceuticals Major industry is somewhat better than the same rating for RMTI (92) in the Medical Specialties industry. This means that AMRX’s stock grew somewhat faster than RMTI’s over the last 12 months.

AMRX's P/E Growth Rating (24) in the Pharmaceuticals Major industry is significantly better than the same rating for RMTI (100) in the Medical Specialties industry. This means that AMRX’s stock grew significantly faster than RMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXRMTI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend about 1 month ago
80%
Bullish Trend 26 days ago
85%
Declines
ODDS (%)
Bearish Trend 24 days ago
78%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBR12.700.30
+2.42%
Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share)
WH79.13-2.26
-2.78%
Wyndham Hotels & Resorts
MOGO1.24-0.05
-3.88%
Mogo
QBTS15.17-0.71
-4.47%
D-Wave Quantum
MLNK15.77-1.21
-7.13%
MeridianLink

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-2.64%
PAHC - AMRX
46%
Loosely correlated
-2.37%
EBS - AMRX
40%
Loosely correlated
-5.30%
AMPH - AMRX
39%
Loosely correlated
-2.34%
ZTS - AMRX
39%
Loosely correlated
-2.66%
VTRS - AMRX
38%
Loosely correlated
-1.87%
More

RMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMTI has been loosely correlated with AVDL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if RMTI jumps, then AVDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMTI
1D Price
Change %
RMTI100%
-3.27%
AVDL - RMTI
34%
Loosely correlated
+2.46%
HROW - RMTI
30%
Poorly correlated
-2.73%
EBS - RMTI
29%
Poorly correlated
-5.30%
CRDL - RMTI
26%
Poorly correlated
+1.39%
AMRX - RMTI
25%
Poorly correlated
-2.64%
More